Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Sep;85(18):6875-9.
doi: 10.1073/pnas.85.18.6875.

Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2

Affiliations

Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2

S Chouaib et al. Proc Natl Acad Sci U S A. 1988 Sep.

Abstract

Large granular lymphocytes (LGL) can be activated by interleukin 2 (IL-2) to lymphokine-activated killers (LAK). The effect of tumor necrosis factor (TNF) on LAK generation was investigated. TNF was found to act synergistically with low concentrations of IL-2 (0.10-0.25 ng/ml), which were ineffective by themselves in inducing LAK activity, to promote the differentiation of LGL into non-major histocompatibility complex-restricted killers. When IL-2 was used at concentrations optimal for LAK generation, TNF did not further enhance this phenomenon. Specific binding of 125I-labeled TNF to LGL was increased by IL-2 stimulation. Scatchard analysis of TNF binding revealed the existence of two classes of binding sites with markedly different affinities (Kd values of 57 and 600 pM). We also demonstrated that the IL-2/TNF synergistic induction of LAK activity did not involve either IL-1 or interferon-gamma. This IL-2/TNF synergistic effect was blocked by anti-Tac antibodies. Immunofluorescence analysis revealed that IL-2/TNF selectively up-regulated Tac antigen expression on LAK precursors. Our results suggest a functional interaction between IL-2 and TNF on LAK precursors, which results in a reduction of the IL-2 concentration required for differentiation of LGL into LAK killers.

PubMed Disclaimer

References

    1. J Exp Med. 1986 Mar 1;163(3):632-43 - PubMed
    1. Science. 1985 Nov 22;230(4728):943-5 - PubMed
    1. J Exp Med. 1986 Jun 1;163(6):1433-50 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5688-92 - PubMed
    1. J Exp Med. 1986 Oct 1;164(4):1193-205 - PubMed

Publication types

LinkOut - more resources